Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.
暂无分享,去创建一个
X. Forns | H. Wedemeyer | J. Calleja | A. Erhardt | R. Sentjens | Y. Benhamou | G. Steinmann | C. Yong | G. Nehmiz | H. Hinrichsen | M. Reiser | R. Chaves | J. Crönlein